FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the first patient implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System after ...
CENTER VALLEY, Pa., Dec. 5, 2025 /PRNewswire/ -- Olympus Corporation ("Olympus"), W. L. Gore & Associates, Inc. ("Gore"), and ConMed Corporation ("ConMed") jointly ...
GORE ® Ascending Stent Graft, an investigational device, is an off-the-shelf endovascular solution designed to treat life-threatening Type A dissections of the ascending aorta FLAGSTAFF, ...
Frankfurt, Germany, April 15, 2021 (GLOBE NEWSWIRE) -- The global pandemic brought office life to its knees, and working from home marched in as the big new ‘I am’. Corporations fell in love with ...
Gore Mutual Insurance Company announced on Thursday that it has partnered with eight insurance brokers to launch uBiz, an ecommerce platform that enables brokers to offer commercial insurance through ...
Gore Mutual Insurance Company is in production with Duck Creek Technologies Inc. to process Gore Mutual’s commercial property policies using Duck Creek’s policy administration system. “This new system ...
(MENAFN- PR Newswire) "This is a landmark indication for a stent graft, equipping physicians with an on-label solution for more patients in complex pathologies," said Prof. Luca Bertoglio, Associate ...
FLAGSTAFF, Ariz.- W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration's (FDA's) premarket approval (PMA) of the GORE® CARDIOFORM ASD Occluder for the percutaneous closure of ...
The GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis indication expansion brings the first bridging stent device with dual indication for both fenestrated and branched endovascular repair*.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback